Recent News

• 02.11.2026 - Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
• 12.01.2025 - Tectonic Therapeutic to Participate in December Investor Conferences
• 11.06.2025 - Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
• 10.29.2025 - Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF

Recent Filings

• 02.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors